Researchers at The University of Texas at Austin have developed a menu of 61 new strains of genetically engineered E. coli that may improve the efficacy of vaccines for diseases such as flu, pertussis, cholera and HPV.
During the last century, scientists at The University of Texas at Austin played a large role in eliminating the nutritional deficiency diseases that were devastating to children's development with discoveries of vitamins like B5 and B6 and folic acid. Today, a multi-disciplinary group of university researchers from the College of Pharmacy and College of Natural… » Continue Reading
A novel delivery system that could lead to more efficient and more disease-specific vaccines against infectious diseases has been developed by biomedical engineers at The University of Texas at Austin.
University of Texas at Austin Pharmacy Researcher Receives $2.6 Million to Develop Vaccine Against Ebola Virus
Dr. Maria Croyle, associate professor of pharmaceutics at The University of Texas at Austin College of Pharmacy, has received $2.6 million to develop a vaccine against Ebola virus infection.